References
- Alexander, S. P., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., Collaborators, C, & CGTP Collaborators (2013). The concise guide to PHARMACOLOGY 2013/14: Nuclear hormone receptors. British Journal of Pharmacology, 170(8), 1652–1675. https://doi.org/https://doi.org/10.1111/bph.12448
- Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., & Kline, S. (2020). Remdesivir for the treatment of Covid-19—preliminary report. New England Journal of Medicine, 1–12.
- Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., Lambert, M. H., Moore, J. T., Pearce, K. H., & Xu, H. E. (2002). Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell, 110(1), 93–105. https://doi.org/https://doi.org/10.1016/s0092-8674(02)00817-6
- Blessy, J. J., & Sharmila, D. J. S. (2015). Molecular simulation of N-acetylneuraminic acid analogs and molecular dynamics studies of cholera toxin-Neu5Gc complex. Journal of Biomolecular Structure & Dynamics, 33(5), 1126–1139. https://doi.org/https://doi.org/10.1080/07391102.2014.931825
- Bo, L., Xiangjun, B., & Haiping, W. (2006). Effect of dexamethasone on expression of glucocorticoid receptor in human monocyte cell line THP-1. Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong ke ji da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban, 26(1), 25–27. https://doi.org/https://doi.org/10.1007/BF02828029
- Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1758788
- Borhani, D. W., & Shaw, D. E. (2012). The future of molecular dynamics simulations in drug discovery. Journal of Computer-Aided Molecular Design, 26(1), 15–26. https://doi.org/https://doi.org/10.1007/s10822-011-9517-y
- Boulanger, M. J., Chow, D-c., Brevnova, E. E., & Garcia, K. C. (2003). Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex . Science (New York, N.Y.), 300(5628), 2101–2104. https://doi.org/https://doi.org/10.1126/science.1083901
- Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/https://doi.org/10.1002/jmv.25681
- Conti, P., Ronconi, G., Caraffa, A., Gallenga, C., Ross, R., Frydas, I., & Kritas, S. (2020). Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J Biol Regul Homeost Agents, 34, 1.
- Dowton, S. B., Waggoner, D. J., & Mandl, K. D. (1991). Developmental regulation of expression of C-reactive protein and serum amyloid A in Syrian hamsters. Pediatric Research, 30(5), 444–449. https://doi.org/https://doi.org/10.1203/00006450-199111000-00010
- Durrant, J. D., & McCammon, J. A. (2011). Molecular dynamics simulations and drug discovery. BMC Biology, 9, 71–79. https://doi.org/https://doi.org/10.1186/1741-7007-9-71
- Eaves, C. J., Cashman, J. D., Kay, R. J., Dougherty, G. J., Otsuka, T., Gaboury, L., Hogge, D., Lansdorp, P., Eaves, A., & Humphries, R. (1991). Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.Blood, 78, 110–117.
- Edman, K., Hosseini, A., Bjursell, M. K., Aagaard, A., Wissler, L., Gunnarsson, A., Kaminski, T., Köhler, C., Bäckström, S., Jensen, T. J., Cavallin, A., Karlsson, U., Nilsson, E., Lecina, D., Takahashi, R., Grebner, C., Geschwindner, S., Lepistö, M., Hogner, A. C., & Guallar, V. (2015). Ligand binding mechanism in steroid receptors: From conserved plasticity to differential evolutionary constraints. Structure (London, England: 1993), 23(12), 2280–2290. https://doi.org/https://doi.org/10.1016/j.str.2015.09.012
- Elfiky, A. A. (2020). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–9.
- Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–13.
- Enayatkhani, M., Hasaniazad, M., Faezi, S., Guklani, H., Davoodian, P., Ahmadi, N., Einakian, M. A., Karmostaji, A., & Ahmadi, K. (2020). Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. Journal of Biomolecular Structure and Dynamics, 1–16.
- Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 1–7.
- Gupta, V., & Wagner, B. (2005). Dexamethasone induces changes in glucocorticoid receptor phosphorylation and gene expression in human lens epithelial cells. Investigative Ophthalmology & Visual Science, 46, 1890.
- Hayes, J. M., & Archontis, G. (2012). MM-GB (PB) SA calculations of protein-ligand binding free energies. Molecular Dynamics-Studies of Synthetic and Biological Macromolecules, 171–190.
- Healthcare, G. (2020). Dexamethasone, an unexpected drug, shows promise in treating Covid-19.
- Herr, I., & Pfitzenmaier, J. (2006). Glucocorticoid use in prostate cancer and other solid tumours: Implications for effectiveness of cytotoxic treatment and metastases. The Lancet Oncology, 7(5), 425–430. https://doi.org/https://doi.org/10.1016/S1470-2045(06)70694-5
- Hideshima, T., Bergsagel, P. L., Kuehl, W. M., & Anderson, K. C. (2004). Advances in biology of multiple myeloma: Clinical applications. Blood, 104(3), 607–618. https://doi.org/https://doi.org/10.1182/blood-2004-01-0037
- Hollander, J. L. (1960). Clinical use of dexamethasone: Role in treatment of patients with arthritis. Journal of the American Medical Association, 172, 306–310. https://doi.org/https://doi.org/10.1001/jama.1960.03020040004002
- Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143.
- Hoover, W. G. (1985). Canonical dynamics: Equilibrium phase-space distributions. Physical Review A, General Physics, 31(3), 1695–1697. https://doi.org/https://doi.org/10.1103/physreva.31.1695
- Horby, P., Lim, W. S., Emberson, J. R., Mafham, M., Bell, J. L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., & Elmahi, E. (2020). Dexamethasone in hospitalized patients with COVID-19-Preliminary Report. The New England journal of medicine.
- Isidori, A. M., Arnaldi, G., Boscaro, M., Falorni, A., Giordano, C., Giordano, R., Pivonello, R., Pofi, R., Hasenmajer, V., Venneri, M. A., Sbardella, E., Simeoli, C., Scaroni, C., & Lenzi, A. (2020). COVID-19 infection and glucocorticoids: Update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. Journal of Endocrinological Investigation, 43(8), 1141–1147. https://doi.org/https://doi.org/10.1007/s40618-020-01266-w
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–285. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/https://doi.org/10.1063/1.445869
- Khan, S. U., & Htar, T. (2020). Deciphering the binding mechanism of Dexamethasone against SARS-CoV-2 Main Protease: Computational molecular modelling approach. ChemRxiv, 1–27.
- Klebe, G., & Böhm, H. J. (1997). Energetic and entropic factors determining binding affinity in protein-ligand complexes. Journal of Receptor and Signal Transduction Research, 17(1–3), 459–473.
- Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins, 79(10), 2794–2812. https://doi.org/https://doi.org/10.1002/prot.23106
- Liu, L., Aleksandrowicz, E., Schönsiegel, F., Gröner, D., Bauer, N., Nwaeburu, C. C., Zhao, Z., Gladkich, J., Hoppe-Tichy, T., Yefenof, E., Hackert, T., Strobel, O., & Herr, I. (2017). Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1 . Cell Death & Disease, 8(10), e3064. https://doi.org/https://doi.org/10.1038/cddis.2017.455
- Liuzzi, J. P., Lichten, L. A., Rivera, S., Blanchard, R. K., Aydemir, T. B., Knutson, M. D., Ganz, T., & Cousins, R. J. (2005). Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proceedings of the National Academy of Sciences of the United States of America, 102(19), 6843–6848. https://doi.org/https://doi.org/10.1073/pnas.0502257102
- Mahmud-Al-Rafat, A., Majumder, A., Rahman, K. T., Hasan, A. M., Islam, K. D., Taylor-Robinson, A. W., & Billah, M. M. (2019). Decoding the enigma of antiviral crisis: Does one target molecule regulate all?. Cytokine, 115, 13–23. https://doi.org/https://doi.org/10.1016/j.cyto.2018.12.008
- Matsuda, T., Yamasaki, K., Taga, T., Hirano, T., & Kishimoto, T. (1989). Current concepts of B cell modulation. International Reviews of Immunology, 5(2), 97–109. https://doi.org/https://doi.org/10.3109/08830188909061976
- Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. (2020). Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure and Dynamics, 1–26.
- Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004). IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. The Journal of Clinical Investigation, 113(9), 1271–1276. https://doi.org/https://doi.org/10.1172/JCI20945
- Nayeem, S. M., & Reddy, M. S. (2020). Target SARS-CoV-2: Computation of Binding energies with drugs of Dexamethasone/Umifenovir by Molecular Dynamics using OPLS-AA force field. Research square, 1–17.
- Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., Hara, M., Taguchi, H., Kimura, Y., Kato, Y., Asaoku, H., Kumagai, S., Kodama, F., Nakahara, H., Hagihara, K., … Kishimoto, T. (2005). Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood, 106(8), 2627–2632. https://doi.org/https://doi.org/10.1182/blood-2004-12-4602
- Organization WH (1977). The selection of essential drugs: report of a WHO expert committee [meeting held in Geneva from 17 to 21 October 1977]. World Health Organization;
- Pace, C. N., Scholtz, J. M., & Grimsley, G. R. (2014). Forces stabilizing proteins. FEBS Letters, 588(14), 2177–2184. https://doi.org/https://doi.org/10.1016/j.febslet.2014.05.006
- Rathnayake, S., & Weerasinghe, S. (2018). Exploring the binding properties of agonists interacting with glucocorticoid receptor: An in silico approach. Journal of Molecular Modeling, 24(12), 342 https://doi.org/https://doi.org/10.1007/s00894-018-3879-1
- Release S. 2 (2017). LigPrep. Schrödinger, LLC.
- Release S. 4 (2017). QikProp. Schrödinger, LLC.
- Release S. 4. (2015). Glide. Schrödinger, LLC (Google Scholar There is no corresponding record for this reference. 2015).
- Roy, S., Kumar, A., Baig, M. H., Masařík, M., & Provazník, I. (2015). Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease. Methods (San Diego, California), 83, 105–110. https://doi.org/https://doi.org/10.1016/j.ymeth.2015.04.021
- Rupprecht, R., Reul, J. M., van Steensel, B., Spengler, D., Söder, M., Berning, B., Holsboer, F., & Damm, K. (1993). Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. European Journal of Pharmacology: Molecular Pharmacology, 247(2), 145–154. https://doi.org/https://doi.org/10.1016/0922-4106(93)90072-H
- Schett, G., Manger, B., Simon, D., & Caporali, R. (2020). COVID-19 revisiting inflammatory pathways of arthritis. Nature Reviews. Rheumatology, 16(8), 465–466. https://doi.org/https://doi.org/10.1038/s41584-020-0451-z
- Sharma, J., Ramanathan, K., & Sethumadhavan, R. (2011). Identification of potential inhibitors against acetylcholinesterase associated with Alzheimer's diseases: A molecular docking approach. Journal of Computational Methods in Molecular Design, 1, 44–51.
- Somers, W., Stahl, M., & Seehra, J. S. (1997). 1.9 A crystal structure of interleukin 6: Implications for a novel mode of receptor dimerization and signaling. The EMBO Journal, 16(5), 989–997. https://doi.org/https://doi.org/10.1093/emboj/16.5.989
- Sorbera, L., Graul, A., & Dulsat, C. (2020). Taking aim at a fast-moving target: Targets to watch for SARS-CoV-2 and COVID-19. Drugs of the Future, 45(4), 239–244. https://doi.org/https://doi.org/10.1358/dof.2020.45.4.3150676
- Stoll, B. A. (1960). Dexamethasone in advanced breast cancer. Cancer, 13(5), 1074–1080. https://doi.org/https://doi.org/10.1002/1097-0142(196009/10)13:5<1074::AID-CNCR2820130531>3.0.CO;2-9
- Subhani, S., Jayaraman, A., & Jamil, K. (2015). Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 71, 37–45. https://doi.org/https://doi.org/10.1016/j.biopha.2015.02.009
- Sze, C.-I., Lin, Y.-C., Lin, Y.-J., Hsieh, T.-H., Kuo, Y. M., & Lin, C.-H. (2013). The role of glucocorticoid receptors in dexamethasone-induced apoptosis of neuroprogenitor cells in the hippocampus of rat pups. Mediators of Inflammation, 2013, 628094. https://doi.org/https://doi.org/10.1155/2013/628094
- Tanaka, T., Narazaki, M., & Kishimoto, T. (2014). IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology, 6(10), a016295. https://doi.org/https://doi.org/10.1101/cshperspect.a016295
- Vijayakumar, S., Manogar, P., Prabhu, S., & Singh, R. A. S. (2018). Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease. Journal of Pharmaceutical Analysis, 8(6), 413–420. https://doi.org/https://doi.org/10.1016/j.jpha.2017.07.006
- Villar, J., Confalonieri, M., Pastores, S. M., & Meduri, G. U. (2020). Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019. Critical Care Explorations, 2, 1–5.
- Volden, P. A., & Conzen, S. D. (2013). The influence of glucocorticoid signaling on tumor progression. Brain, Behavior, and Immunity, 30, S26–S31. https://doi.org/https://doi.org/10.1016/j.bbi.2012.10.022
- Xu, M., Song, L., & Wang, Z. (2003). Effects of Dexamethasone on glucocorticoid receptor expression in a human ovarian carcinoma cell line 3AO. Chinese Medical Journal (England), 116, 392–395.
- Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/https://doi.org/10.1128/JVI.02114-07
- Zhang, C., Kolb, A., Büchler, P., Cato, A. C. B., Mattern, J., Rittgen, W., Edler, L., Debatin, K.-M., Büchler, M. W., Friess, H., & Herr, I. (2006). Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer. BMC Cancer, 6, 61. https://doi.org/https://doi.org/10.1186/1471-2407-6-61
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405
- Zhang, X., Zhang, Z., Ju, M., Li, J., Jing, Y., Zhao, Y., Gu, C., Dong, M., Li, G., & Liu, Y. (2020). Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression. Inflammopharmacology, 1–13.
- Zhavoronkov, A., Zagribelnyy, B., Zhebrak, A., Aladinskiy, V., Terentiev, V., Vanhaelen, Q., Bezrukov, D. S., Polykovskiy, D., Shayakhmetov, R., & Filimonov, A. (2020). Potential non-covalent SARS-CoV-2 3C-like protease inhibitors designed using generative deep learning approaches and reviewed by human medicinal chemist in virtual reality. ChemRxiv, 1–18.